Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepatocellular carcinoma (HCC), associated barriers, and proposed solutions: results of a survey of physicians from all major provinces of Mongolia
Authors
J. Estevez
Division of Gastroenterology and Hepatology at Stanford University, California, USA
Y.A. Kim
Division of Gastroenterology and Hepatology at Stanford University, California, USA
A. Le
Division of Gastroenterology and Hepatology at Stanford University, California, USA
D. Israelski
Center for Innovation In Global Health at Stanford University, California, USA
O. Baatarkhuu
Department of Infectious Diseases at Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
T. Sarantuya
Internal Medicine Department at United Family Intermed Hospital, Ulaanbaatar, Mongolia
S. Narantsetseg
The Third State Central Hospital of Mongolia, Ulaanbaatar, Mongolia
P. Nymadawa
Public Health Branch, Mongolian Academy of Medical Sciences, Ulaanbaatar, Mongolia
H. Le
Division of Gastroenterology and Hepatology at Stanford University, California, USA
M.F. Yuen
Division of Gastroenterology and Hepatology at Queen Mary Hospital, Hong Kong
G. Dusheiko
Royal Free Hospital and University College London School of Medicine in London, United Kingdom
M. Rizzetto
Department of Gastroenterology at the University of Torino, Torino, Italy
M.H. Nguyen
Division of Gastroenterology and Hepatology at Stanford University, California, USA
DOI: https://doi.org/10.1016/j.aogh.2016.04.159 | Journal eISSN: 2214-9996
Language: English
Page range: 416 - 416
Published on: Aug 20, 2016
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2016 J. Estevez, Y.A. Kim, A. Le, D. Israelski, O. Baatarkhuu, T. Sarantuya, S. Narantsetseg, P. Nymadawa, H. Le, M.F. Yuen, G. Dusheiko, M. Rizzetto, M.H. Nguyen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.